Filament's patent describes the extraction of stable, standardized doses of psychoactive compounds at its Health Canada-licensed, GMP-certified facility VANCOUVER, BC, Aug. 3, 2021 /CNW/ - Filament ...
Filament Health will supply its standardized, patented PEX010 botanical psilocybin drug candidate, produced using proprietary extraction and stabilization methods to an independently sponsored UCSF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results